Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Markstein

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1996
SDZ GLC 756, a novel octahydrobenzo[g]quinoline derivative exerts opposing effects on dopamine D1 and D2 receptorsR Markstein, P Gull, C Rüdeberg, et al.
Experientia|May 15, 1988
Pharmacodynamic profile of CQP 201-403, a novel 8 alpha-amino-ergolineE Flückiger, U Briner, B Clark, et al.
Synapse (New York, N.Y.)|February 1, 1997
Dopamine D2-like sites in schizophrenia, but not in Alzheimer's, Huntington's, or control brains, for [3H]benzquinolineP Seeman, H C Guan, J Nobrega, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989
Antiparkinsonian activity of CY 208-243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's diseaseJ A Temlett, N P Quinn, P G Jenner, et al.
Synapse (New York, N.Y.)|November 24, 1998
Imaging dopamine D4 receptors in the living primate brain: a positron emission tomography study using the novel D1/D4 antagonist [11C]SDZ GLC 756C Boy, A Klimke, M Holschbach, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1996
SDZ GLC 756, a novel octahydrobenzo[g]quinoline derivative exerts opposing effects on dopamine D1 and D2 receptorsR Markstein, P Gull, C Rüdeberg, et al.
Experientia|May 15, 1988
Pharmacodynamic profile of CQP 201-403, a novel 8 alpha-amino-ergolineE Flückiger, U Briner, B Clark, et al.
Synapse (New York, N.Y.)|February 1, 1997
Dopamine D2-like sites in schizophrenia, but not in Alzheimer's, Huntington's, or control brains, for [3H]benzquinolineP Seeman, H C Guan, J Nobrega, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989
Antiparkinsonian activity of CY 208-243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's diseaseJ A Temlett, N P Quinn, P G Jenner, et al.
Synapse (New York, N.Y.)|November 24, 1998
Imaging dopamine D4 receptors in the living primate brain: a positron emission tomography study using the novel D1/D4 antagonist [11C]SDZ GLC 756C Boy, A Klimke, M Holschbach, et al.
Pageof 5